Protection of jeopardized ischemic myocardium by reduction of ventricular afterload.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006352:Heart Ventricles; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology*; D014294:Trimethaphan / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
D014294:Trimethaphan; D003402:Creatine Kinase